|
HIGD1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.31670000458328E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.15159999500992E-08 |
| Normal-vs-Stage2 |
3.722200E-02 |
| Normal-vs-Stage3 |
1.70149999978442E-07 |
| Normal-vs-Stage4 |
1.95409999292906E-09 |
| Stage1-vs-Stage2 |
8.719500E-02 |
| Stage1-vs-Stage3 |
3.244400E-01 |
| Stage1-vs-Stage4 |
2.864400E-03 |
| Stage2-vs-Stage3 |
2.072500E-02 |
| Stage2-vs-Stage4 |
5.770600E-04 |
| Stage3-vs-Stage4 |
4.434500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.69440025846279E-10 |
| Normal-vs-AfricanAmerican |
1.053770E-02 |
| Normal-vs-Asian |
5.60039999999429E-05 |
| Caucasian-vs-AfricanAmerican |
2.144800E-01 |
| Caucasian-vs-Asian |
7.322800E-01 |
| AfricanAmerican-vs-Asian |
4.267800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.79990003088693E-09 |
| Normal-vs-Female |
2.00949999973332E-07 |
| Male-vs-Female |
7.412000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.11119999979259E-07 |
| Normal-vs-Age(41-60Yrs) |
8.22839999470304E-08 |
| Normal-vs-Age(61-80Yrs) |
1.426910E-04 |
| Normal-vs-Age(81-100Yrs) |
1.203580E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.052200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.992400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.763800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.552200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.494600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.981200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.137800E-01 |
| Classical-VS-Follicular |
1.557970E-03 |
| Classical-VS-Other |
8.167200E-01 |
| Classical-VS-Normal |
4.65590010989558E-10 |
| Tall-VS-Follicular |
9.161800E-03 |
| Tall-VS-Other |
9.036600E-01 |
| Tall-VS-Normal |
1.61604999999732E-05 |
| Follicular-VS-Other |
2.405800E-01 |
| Follicular-VS-Normal |
3.886100E-02 |
| Other-VS-Normal |
1.941600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00859999996317E-06 |
| Normal-vs-N1 |
1.06580000380774E-08 |
| N0-vs-N1 |
2.207600E-02 |
|
|
